PAP2(Production of anthocyanin pigment 2)编码MYB转录因子,与bHLH、WD40形成MYB-bHLH-WD40复合体来调控花青素合成。本研究从埃塞俄比亚芥和黑芥中分别克隆出2个和1个PAP2基因拷贝,分别命名为BcaB.PAP2、BcaC.PAP2、BniB.PAP2,这三...PAP2(Production of anthocyanin pigment 2)编码MYB转录因子,与bHLH、WD40形成MYB-bHLH-WD40复合体来调控花青素合成。本研究从埃塞俄比亚芥和黑芥中分别克隆出2个和1个PAP2基因拷贝,分别命名为BcaB.PAP2、BcaC.PAP2、BniB.PAP2,这三个基因均由3个外显子和2个内含子组成,均编码247个氨基酸。基于本研究克隆的PAP2基因序列和已报道的其他芸薹属PAP2基因序列,设计了3对能分别检测A、B、C基因组PAP2基因的引物,通过等位特异PCR可以区分芸薹属禹氏三角中的6个物种PAP2的基因组来源。选取芥菜型油菜B基因组的BjuB.PAP2基因构建过表达载体,转化拟南芥,其叶片变紫,表明PAP2基因正调控花青素合成。遮光处理10天后紫叶埃塞俄比亚芥的叶片紫色变淡,花青素含量下降了41.22%。荧光定量PCR和转录组研究表明,遮光处理植株叶片中BcaB.PAP2和BcaC.PAP2表达量均下降,花青素合成的结构基因查尔酮合成酶基因(CHS)、查尔酮异构酶基因(CHI)、黄烷酮3-羟化酶基因(F3H)、二氢黄酮醇还原酶基因(DFR)、花青素合成酶基因(ANS)、类黄酮3-葡糖基转移酶基因(UFGT)等基因的表达量也下降。本研究完成了对芸薹属植物中埃塞俄比亚芥和黑芥PAP2基因的克隆,并对其进行进化分析。根据本实验中克隆及其他已报道的PAP2基因序列设计等位基因特异性PCR引物,为芸薹属种间杂交后代PAP2基因的基因组传递鉴定提供了分子标记。通过BjuB.PAP2基因转拟南芥植株结果表明PAP2基因参与花青素的积累。紫叶埃塞俄比亚芥经遮光处理后,发现BcaPAP2基因及花青素合成结构基因的表达受光照的诱导。本研究在芸薹属中克隆PAP2基因,并初步验证PAP2的功能,为进一步解析芸薹属植物花青素合成的调控机制提供参考。展开更多
AIM： To investigate the presence of human papillomavirus （HPV） in esophageal squamous papilloma （ESP） and determine p16, p53 and Ki67 expression in a Mexican cohort. METHODS： Nineteen cases diagnosed as ESP,...AIM： To investigate the presence of human papillomavirus （HPV） in esophageal squamous papilloma （ESP） and determine p16, p53 and Ki67 expression in a Mexican cohort. METHODS： Nineteen cases diagnosed as ESP, corresponding to 18 patients were reviewed; nineteen cases of normal esophageal mucosa were used as negative controls. HPV detection was performed by ,amplified chromogenic in situ hybridization （ACISH） using a wide spectrum-cocktail probe and PCR. RESULTS： The average age at presentation was 46.3 years （range 28-72 years）. Patients included four （22.22%） males and 14 （77.77%） females. The most frequent location was upper third （11 cases）, followed by middle third （3 cases） and unknown site （5 cases）. Immunohistochemistry （IHC） revealed basal and focal p53 expression in 17 cases （89%）; p16 was expressed in eight cases （42.10%） and the Ki67 index ranged from 10% to 30%. HPV was detected in 14 out of 16 cases （87.5%） by ACISH： Twelve showed diffuse nuclear patterns and two showed granular patterns. HPV DNA was identified by PCR in 12 out of 14 cases （85.7%）. Low-risk HPV types were detected in the most of the cases. CONCLUSION： This study provides identification of HPV infection in almost 80% of ESP using either ACISH or PCR; overall, all of these lesions show low expression of cell-cycle markers. We suggest ACISH as an alternative diagnostic tool for HPV detection in ESR .展开更多
目的探讨血清磷脂酰肌醇蛋白聚糖-3(phosphatidylinositol proteoglycan-3,GPC-3)、前列腺酸性磷酸酶(prostatic acid phosphatase,PAP)、前列腺癌抗原-2(prostate cancer antigen-2,EPCA-2)及联合前列腺特异性抗原(prostatic specific ...目的探讨血清磷脂酰肌醇蛋白聚糖-3(phosphatidylinositol proteoglycan-3,GPC-3)、前列腺酸性磷酸酶(prostatic acid phosphatase,PAP)、前列腺癌抗原-2(prostate cancer antigen-2,EPCA-2)及联合前列腺特异性抗原(prostatic specific antigen,PSA)检测在前列腺癌中的诊断价值.方法选取确诊的78例前列腺癌患者(前列腺癌组)和50例良性前列腺增生患者(前列腺增生组)作为研究对象,并选取同期与之配对的80例男性健康体检者作为对照组.用酶联免疫吸附试验检测血清GPC-3、PAP和EPCA-2水平,用时间分辨荧光分析法检测血清PSA水平,并绘制受试者工作特征(ROC)曲线分析GPC-3、PAP、EPCA-2和PSA对前列腺癌的诊断价值.结果前列腺癌组、前列腺增生组和对照组血清GPC-3、PAP、EPCA-2和PSA依次降低,3组比较差异均有统计学意义(P<0.05).血清GPC-3、PAP、EPCA-2和PSA 4个单项指标对前列腺癌均有一定的诊断价值,其敏感度及特异度分别为62.48%、63.31%,64.82%、60.19%,66.55%、63.33%,68.15%、65.92%(P=0.041、0.045、0.038、0.024);但联合检测可明显提高其诊断效能,以GPC-3+PAP+EPCA-2+PSA联合检测效果最佳,其敏感度和特异度分别为95.78%和92.89%.结论血清GPC-3、PAP、EPCA-2及PSA对前列腺癌均有一定诊断价值,但联合检测可明显提高其诊断效果,尤以GPC-3、PAP、EPCA-2及PSA四者联合效能最佳.展开更多
Introduction: The differentiation of digestive tumors very often requires the use of techniques currently not widely in use in the Democratic Republic of Congo (DRC), such as immunohistochemistry. This is perfectly ve...Introduction: The differentiation of digestive tumors very often requires the use of techniques currently not widely in use in the Democratic Republic of Congo (DRC), such as immunohistochemistry. This is perfectly verified for GISTs whose precise, or at least highly certain, diagnosis can only be made using immunohistochemical markers. This underuse of these techniques due to lack of equipment and human skills explains the limited epidemiological data available to date, thus leading to untargeted and too often late treatment of patients. Research question: What contribution can immunohistochemical markers make to the diagnosis of digestive tract tumours? Objective: Discuss the contribution of immunohistochemical markers in the diagnosis of GIST and provide basic data on the epidemiology of these nosological entities in Kinshasa. Methodology: This was a retrospective study carried out at the LEBOMA private anatomy and pathological cytology centre. The main inclusion criterion was any digestive tract block or slide whose diagnosis of GIST had been requalified after review by at least 2 pathologists. An immuhistochemical study was performed using an automated technique (with a Ventana XT machine) using a panel of antibodies: CD-117 and DOG-1 which are listed in the literature as strongly correlated with the occurrence of GIST, all slides were made at Hj Hospital using an OLYMPUS BX41 co-observation microscope. Results: Of 601 cases of digestive tumors recorded during the concerned period, 32 (5.32%) concerned GIST. This prevalence was confirmed by our immunohistochemical results where the expression of CD117 and that of DOG-1 were positive in 90.6% and 100% of cases which prevalence is high compared with the worldwide prevalence according to the literature, respectively. The distribution of the patients concerned was made with a sex ratio of 1.6 women/men with a median age of 53 years. Most cases (81%) had a gastric location and were fusiform GISTs. Conclusion: Gastrointestinal stromal tumours, although rare and underestimated, account for 5.32% of cases in the DRC. This is a considerable and high prevalence compared with the world average. To the best of our knowledge, no studies have been carried out on these aspects in the DRC, which explains the importance of this study. The results of this research demonstrated the contribution of these 2 markers as specific and effective biomarkers for optimal and differential diagnosis in GIST. In view of the above, it is therefore more than necessary to popularise the use of these biomarkers in order to contribute effectively to improving the overall management of gastrointestinal tumours by improving their identification.展开更多
文摘PAP2(Production of anthocyanin pigment 2)编码MYB转录因子,与bHLH、WD40形成MYB-bHLH-WD40复合体来调控花青素合成。本研究从埃塞俄比亚芥和黑芥中分别克隆出2个和1个PAP2基因拷贝,分别命名为BcaB.PAP2、BcaC.PAP2、BniB.PAP2,这三个基因均由3个外显子和2个内含子组成,均编码247个氨基酸。基于本研究克隆的PAP2基因序列和已报道的其他芸薹属PAP2基因序列,设计了3对能分别检测A、B、C基因组PAP2基因的引物,通过等位特异PCR可以区分芸薹属禹氏三角中的6个物种PAP2的基因组来源。选取芥菜型油菜B基因组的BjuB.PAP2基因构建过表达载体,转化拟南芥,其叶片变紫,表明PAP2基因正调控花青素合成。遮光处理10天后紫叶埃塞俄比亚芥的叶片紫色变淡,花青素含量下降了41.22%。荧光定量PCR和转录组研究表明,遮光处理植株叶片中BcaB.PAP2和BcaC.PAP2表达量均下降,花青素合成的结构基因查尔酮合成酶基因(CHS)、查尔酮异构酶基因(CHI)、黄烷酮3-羟化酶基因(F3H)、二氢黄酮醇还原酶基因(DFR)、花青素合成酶基因(ANS)、类黄酮3-葡糖基转移酶基因(UFGT)等基因的表达量也下降。本研究完成了对芸薹属植物中埃塞俄比亚芥和黑芥PAP2基因的克隆,并对其进行进化分析。根据本实验中克隆及其他已报道的PAP2基因序列设计等位基因特异性PCR引物,为芸薹属种间杂交后代PAP2基因的基因组传递鉴定提供了分子标记。通过BjuB.PAP2基因转拟南芥植株结果表明PAP2基因参与花青素的积累。紫叶埃塞俄比亚芥经遮光处理后,发现BcaPAP2基因及花青素合成结构基因的表达受光照的诱导。本研究在芸薹属中克隆PAP2基因,并初步验证PAP2的功能,为进一步解析芸薹属植物花青素合成的调控机制提供参考。
文摘AIM： To investigate the presence of human papillomavirus （HPV） in esophageal squamous papilloma （ESP） and determine p16, p53 and Ki67 expression in a Mexican cohort. METHODS： Nineteen cases diagnosed as ESP, corresponding to 18 patients were reviewed; nineteen cases of normal esophageal mucosa were used as negative controls. HPV detection was performed by ,amplified chromogenic in situ hybridization （ACISH） using a wide spectrum-cocktail probe and PCR. RESULTS： The average age at presentation was 46.3 years （range 28-72 years）. Patients included four （22.22%） males and 14 （77.77%） females. The most frequent location was upper third （11 cases）, followed by middle third （3 cases） and unknown site （5 cases）. Immunohistochemistry （IHC） revealed basal and focal p53 expression in 17 cases （89%）; p16 was expressed in eight cases （42.10%） and the Ki67 index ranged from 10% to 30%. HPV was detected in 14 out of 16 cases （87.5%） by ACISH： Twelve showed diffuse nuclear patterns and two showed granular patterns. HPV DNA was identified by PCR in 12 out of 14 cases （85.7%）. Low-risk HPV types were detected in the most of the cases. CONCLUSION： This study provides identification of HPV infection in almost 80% of ESP using either ACISH or PCR; overall, all of these lesions show low expression of cell-cycle markers. We suggest ACISH as an alternative diagnostic tool for HPV detection in ESR .
文摘目的探讨血清磷脂酰肌醇蛋白聚糖-3(phosphatidylinositol proteoglycan-3,GPC-3)、前列腺酸性磷酸酶(prostatic acid phosphatase,PAP)、前列腺癌抗原-2(prostate cancer antigen-2,EPCA-2)及联合前列腺特异性抗原(prostatic specific antigen,PSA)检测在前列腺癌中的诊断价值.方法选取确诊的78例前列腺癌患者(前列腺癌组)和50例良性前列腺增生患者(前列腺增生组)作为研究对象,并选取同期与之配对的80例男性健康体检者作为对照组.用酶联免疫吸附试验检测血清GPC-3、PAP和EPCA-2水平,用时间分辨荧光分析法检测血清PSA水平,并绘制受试者工作特征(ROC)曲线分析GPC-3、PAP、EPCA-2和PSA对前列腺癌的诊断价值.结果前列腺癌组、前列腺增生组和对照组血清GPC-3、PAP、EPCA-2和PSA依次降低,3组比较差异均有统计学意义(P<0.05).血清GPC-3、PAP、EPCA-2和PSA 4个单项指标对前列腺癌均有一定的诊断价值,其敏感度及特异度分别为62.48%、63.31%,64.82%、60.19%,66.55%、63.33%,68.15%、65.92%(P=0.041、0.045、0.038、0.024);但联合检测可明显提高其诊断效能,以GPC-3+PAP+EPCA-2+PSA联合检测效果最佳,其敏感度和特异度分别为95.78%和92.89%.结论血清GPC-3、PAP、EPCA-2及PSA对前列腺癌均有一定诊断价值,但联合检测可明显提高其诊断效果,尤以GPC-3、PAP、EPCA-2及PSA四者联合效能最佳.
文摘Introduction: The differentiation of digestive tumors very often requires the use of techniques currently not widely in use in the Democratic Republic of Congo (DRC), such as immunohistochemistry. This is perfectly verified for GISTs whose precise, or at least highly certain, diagnosis can only be made using immunohistochemical markers. This underuse of these techniques due to lack of equipment and human skills explains the limited epidemiological data available to date, thus leading to untargeted and too often late treatment of patients. Research question: What contribution can immunohistochemical markers make to the diagnosis of digestive tract tumours? Objective: Discuss the contribution of immunohistochemical markers in the diagnosis of GIST and provide basic data on the epidemiology of these nosological entities in Kinshasa. Methodology: This was a retrospective study carried out at the LEBOMA private anatomy and pathological cytology centre. The main inclusion criterion was any digestive tract block or slide whose diagnosis of GIST had been requalified after review by at least 2 pathologists. An immuhistochemical study was performed using an automated technique (with a Ventana XT machine) using a panel of antibodies: CD-117 and DOG-1 which are listed in the literature as strongly correlated with the occurrence of GIST, all slides were made at Hj Hospital using an OLYMPUS BX41 co-observation microscope. Results: Of 601 cases of digestive tumors recorded during the concerned period, 32 (5.32%) concerned GIST. This prevalence was confirmed by our immunohistochemical results where the expression of CD117 and that of DOG-1 were positive in 90.6% and 100% of cases which prevalence is high compared with the worldwide prevalence according to the literature, respectively. The distribution of the patients concerned was made with a sex ratio of 1.6 women/men with a median age of 53 years. Most cases (81%) had a gastric location and were fusiform GISTs. Conclusion: Gastrointestinal stromal tumours, although rare and underestimated, account for 5.32% of cases in the DRC. This is a considerable and high prevalence compared with the world average. To the best of our knowledge, no studies have been carried out on these aspects in the DRC, which explains the importance of this study. The results of this research demonstrated the contribution of these 2 markers as specific and effective biomarkers for optimal and differential diagnosis in GIST. In view of the above, it is therefore more than necessary to popularise the use of these biomarkers in order to contribute effectively to improving the overall management of gastrointestinal tumours by improving their identification.
